Neurological Diseases: Novel Biomarkers for Diagnosis and Management
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Clinical Diagnosis and Prognosis".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 691
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue focuses on the latest findings on novel biomarkers for the diagnosis and management of neurological diseases. The diagnosis of neurological disorders commonly relies on clinical assessment. However, symptoms may be subtle, especially at the early stages, and different pathologies may show overlapping symptoms. Moreover, different diseases with similar symptoms as well as distinct subtypes of the same disease may show differences in therapy response and outcome. In this context, biomarkers deriving from laboratory tests, multi-omics approaches, and neuroimaging techniques may be applied to the early detection of disease, differential diagnosis, and the prediction of disease evolution, collectively improving patient management. Overall, this Special Issue aims at proposing novel strategies for the diagnosis and management of neurological diseases to be applied in clinical practice.
Dr. Costanza Maria Cristiani
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomarkers
- laboratory medicine
- neuroimaging
- neurological diseases
- treatment
- management
- clinical diagnostics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
